Nonimmune Hydrops Fetalis Secondary to Fetomaternal Hemorrhage: A Report of Two Cases

Although intrauterine transfusion may be warranted for fetomaternal hemorrhage with secondary nonimmune hydrops, delivery is the preferred treatment if the prognosis for neonatal survival is good. A 31-week fetus with a biophysical profile score of 2 improved after a transfusion, but persistent hemorrhage required a second transfusion and delivery. A 32-week fetus with a score of 10 was delivered without transfusion. Both neonates did well.